Comparing Patient Preferences for Antithrombotic Treatment During the Acute and Chronic Phases of Myocardial Infarction: A Discrete-Choice Experiment
ConclusionPatient preferences for antithrombotic treatments were unaffected by disease stage but varied by bleeding risk and other factors. This heterogeneity in preferences is an important consideration because it can affect the benefit –risk balance and the acceptability of antithrombotic treatments to patients.
Source: The Patient - Patient-Centered Outcomes Research - Category: International Medicine & Public Health Source Type: research
More News: Bleeding | Cardiology | Cardiovascular | Heart | Heart Attack | Hemorrhagic Stroke | International Medicine & Public Health | Ischemic Stroke | Stroke | Study